TMCnet News
Körber and Vineti Announce Partnership to Provide Improved Manufacturing Performance and Visibility Globally for Cell and Gene-Based Therapies
LÜNEBURG, Germany and SAN FRANCISCO, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Körber, the leading MES supplier for pharma and biotech, and Vineti, the world’s only enterprise software platform supporting supply chain orchestration for clinical and commercial cell and gene therapies, today announced a partnership to integrate Werum PAS-X MES with Vineti’s industry-leading Personalized Therapy Management® (PTM) platform. The partnership will empower biopharma customers with an integrated PAS-X MES and supply chain and data management solution to bring life-saving cell and gene-based therapies to patients in need. Advanced therapies, such as cell and gene therapies and personalized vaccines require advanced software infrastructure across the entire production process. The advanced therapy industry requires digital visibility, automation, and real-time feedback in its technology, enabling management of complex manufacturing, large volumes of data and complex, high-risk patient safety requirements. Körber’s and Vineti’s global, non-exclusive partnership between two leading innovators in cell and gene therapy will ensure complete Chain of Identity (COI) and Chain of Custody (COC) visibility, product tracking, and data management as personalized cell and gene therapies go through each step in the manufacturing supply chain, ensuring that every patient receives his or her personalized medicine as quickly and safely as possible. “This cooperation with Vineti shows our continued effort to save lives by providing the best solutions for cell- and gene-based therapies worldwide as the leading strategic partner," said Jens Woehlbier, CEO Software of Körber Business Area Pharma. With its Werum PAS-X MES software, Körber is the market leader in digital manufacturing solutions for the cell and gene industry. Werum PAS-X is run by more than half of the world’s top 30 phrmaceutical and biotech companies and operates in more than 1000 installations around the globe. By integrating Vineti’s Personalized Therapy Management® (PTM) platform with Werum PAS-X MES, this partnership will enable operational excellence and advanced cell and gene therapies out of the box. The joint solution will simplify compliance with all regulatory requirements, and offer easier, faster manufacturing processes. “Patients will always be our priority and at the forefront of the work we do,” said Vineti CEO and Co-founder Amy DuRoss. “By partnering with Körber, we will be providing a greater opportunity for the industrialization of cell and gene therapy manufacturing and supply chain. This partnership will allow Vineti to seamlessly integrate with the top manufacturers around the world, positioning Körber and Vineti to best help customers globally as the cell and gene therapy space grows in the years to come.” This partnership follows Körber’s recent announcement that its Werum PAS-X software has been named a Leader in the Gartner Magic Quadrant for Manufacturing Execution Systems 2021 and Vineti’s release of its PTM Essentials™ solution for clinical-phase advanced therapies. More information on the Körber-Vineti solution is available through both company’s business development teams. About Körber The Körber Business Area Pharma delivers the difference along the pharma value chain with its unique portfolio of integrated solutions. With their software solutions Körber helps drug manufacturers to digitize their pharma, biotech and cell & gene factories. The software product Werum PAS-X MES is recognized as the world’s leading Manufacturing Execution System for the pharma & biotech industry. Körber’s data analytics and AI solutions accelerate product commercialization and uncover hidden business value. About Vineti Media Contacts Körber Business Area Pharma Vineti |